InvestorsHub Logo
Followers 63
Posts 8502
Boards Moderated 0
Alias Born 01/10/2014

Re: None

Monday, 10/14/2019 5:39:55 PM

Monday, October 14, 2019 5:39:55 PM

Post# of 328
Great News !!

Aclaris Therapeutics, Inc. ACRS announced that it has sold worldwide rights to its rosacea drug, Rhofade Cream, and certain licenses to related intellectual property assets to privately-held wholesale distributor of prescription drugs, EPI Health for $55 million. The divestiture is part of Aclaris’ ongoing restructuring program to focus on its immuno-inflammatory pipeline.



https://finance.yahoo.com/news/aclaris-divests-rhofade-epi-health-142802575.html

Statements made are only my opinion. Do your own DD in order to make your Investment decisions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACRS News